The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...

Biodesix announces positive study data for its Nodify CDT blood-based lung nodule test published in CHEST Pulmonary Journal.

(Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced a new post-market clinical validation study was published in CHEST Pulmonary Journal that reaffirms the ...

A study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...

Eli Lilly (NYSE:LLY) has entered into a licensing agreement with Mediar Therapeutics to advance Mediar's drug MTX-463 into ...

A noninvasive approach could help clinicians prescribe medications more precisely for patients according to endotype.

Given the overlap in symptoms, laboratory testing is required to distinguish between RSV and HMPV, the gold standard for detecting both viruses. While quick antigen tests are available for RSV, their ...

UW-Madison has earned a $5.7 million grant to test the effects of vaping on cardio-pulmonary health over the course of three ...

Tectonic's lead asset, TX45, is a long-acting Fc-relaxin fusion protein to treat group 2 pulmonary hypertension. Read why I'm ...

"Although e-cigarettes have been on the market for over 15 years, we really don't know anything about their long-term health ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).